Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | SLC5A7 | Q9GZV3 | 1/20 | 0.45 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.44 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.42 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.42 |
| ▸ | MMP2 | P08253 | 2/20 | 0.42 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.42 |
| ▸ | RAD52 | P43351 | 1/20 | 0.42 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28002637 | 0.97 | CYP3A4 (0.50) | LMNAMEN1KMT2ACYP3A4SLC5A7 | |
| Bromide SCHEMBL30645628 | 0.97 | MEN1 (0.50) | LMNAMEN1KMT2ACYP3A4SLC5A7 | |
| Formic Acid SCHEMBL11663826 | 0.89 | PSMD14 (0.41) | LMNAMEN1KMT2ACYP3A4SLC5A7 | |
| SCHEMBL159367 | 0.87 | MEN1 (0.56) | LMNAMEN1KMT2ACYP3A4SLC5A7 | |
| Formic Acid SCHEMBL11663824 | 0.85 | PSMD14 (0.39) | LMNAMEN1KMT2ACYP3A4SLC5A7 | |
| SCHEMBL14123849 | 0.83 | DNM1 (0.34) | LMNAMEN1KMT2ACYP3A4SLC5A7 | |
| SCHEMBL20201348 | 0.83 | SMN1; SMN2 (0.39) | LMNAMEN1KMT2ACYP3A4SLC5A7 | |
| Hydrochloric Acid SCHEMBL2444152 | 0.83 | CYP3A4 (0.62) | LMNAMEN1KMT2ACYP3A4SLC5A7 | |
| Water SCHEMBL490994 | 0.83 | MEN1 (0.53) | LMNAMEN1KMT2ACYP3A4SLC5A7 | |
| SCHEMBL10416316 | 0.83 | MEN1 (0.53) | LMNAMEN1KMT2ACYP3A4SLC5A7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11858961-B2 | Solutions of quaternary and tertiary ammonium cation detergents to denature proteins, and kits for making them | AGILENT TECHNOLOGIES, INC. (US) | 2024-01-02 | — | — | US | disclosed |
| US-11111268-B2 | Use of quaternary and tertiary ammonium cations to denature proteins | AGILENT TECHNOLOGIES, INC. (US) | 2021-09-07 | — | — | US | disclosed |
| CN-106398581-B | Antistatic agent for adhesive | 第一工业制药株式会社 | 2020-06-23 | — | — | CN | disclosed |
| US-20190169230-A1 | Use of Quaternary and Tertiary Ammonium Cations to Denature Proteins | PROZYME, INC. (US) | 2019-06-06 | — | — | US | disclosed |
| US-20130156992-A1 | ANTISTATIC POLYESTER RESIN MOLDED BODY | CANON KABUSHIKI KAISHA (JP) | 2013-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11111268-B2 | Use of quaternary and tertiary ammonium cations to denature proteins | PDIA3, STOM, PDIA6 | LMNA 2506/4885MEN1 4729/4885KMT2A 4084/4885 |
| US-20190169230-A1 | Use of Quaternary and Tertiary Ammonium Cations to Denature Proteins | PDIA3, STOM, PDIA6 | LMNA 2506/4885MEN1 4729/4885KMT2A 4084/4885 |
| US-11858961-B2 | Solutions of quaternary and tertiary ammonium cation detergents to denature proteins, and kits for making them | STOM, PDIA3, PDIA5 | LMNA 2392/4885MEN1 4680/4885KMT2A 4227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.